Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Isosorbide mononitrate 40mg modified-release tablets |
| BNF code | 0206010K0AAAGAG |
| Virtual Therapeutic Moiety | Isosorbide mononitrate |
| Date identifier became valid | 23 Sep 2020 |
| Previous product identifier | 319124005 |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | tablet |
| Unit dose unit of measure | tablet |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Isosorbide mononitrate |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 40.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | tabletmodified-release.oral |
| Dose Form | |
| Formulation | Modified-release tablet |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Eumon 40 XL tablets (Tillomed Laboratories Ltd) | |
| Ismo Retard 40mg tablets (Esteve Pharmaceuticals Ltd) | |
| Isotard 40XL tablets (Evolan Pharma AB) | |
| Modisal XL 40mg tablets (Ennogen Healthcare International Ltd) | |
| Zemon 40 XL tablets (Kent Pharma (UK) Ltd) | |
| Virtual Medicinal Product Packs | |
| Isosorbide mononitrate 40mg modified-release tablets 28 tablet | |
| Isosorbide mononitrate 40mg modified-release tablets 30 tablet | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.